Previous research has revealed a link between VAV3 and inflammation and infection (Zhang et al., 2023; Roth et al., 2016), with studies showing that overexpression of VAV3 could mitigate cardiomyocyte inflammation and apoptosis in rats with myocardial infarction (Zhang et al., 2023). Here, VAV3 is linked to myocardial infarction.